When converting a patient on Novolin 70/30 (human insulin 70% NPH, 30% regular) U-100 who takes 20 U in the morning, 26 U at noon, and 22 U in the evening to Novolog (insulin aspart), how many total units of Novolog are needed per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Converting from Novolin 70/30 to NovoLog: Dosing Strategy

You cannot simply convert Novolin 70/30 to NovoLog unit-for-unit because they are fundamentally different insulin formulations—Novolin 70/30 is a premixed insulin containing both basal (NPH) and prandial (regular) components, while NovoLog is a rapid-acting prandial-only insulin that requires separate basal insulin coverage.

Understanding the Problem

The patient is currently taking 68 units total daily of Novolin 70/30 (20 + 26 + 22 units). This premixed formulation contains:

  • 70% NPH (intermediate-acting basal insulin) = ~48 units basal coverage
  • 30% regular insulin (short-acting prandial) = ~20 units prandial coverage

NovoLog is a rapid-acting analog with onset in 40-50 minutes and duration of 3-5 hours 11—it provides only prandial coverage with no basal component.

The Correct Conversion Approach

Based on the 2025 ADA Standards of Care, you must transition to a basal-bolus regimen, not just switch to NovoLog alone 2222. Here's the algorithmic approach:

Step 1: Calculate Basal Insulin Needs

  • Total current insulin: 68 units/day
  • Estimated basal component (70% of premix): ~48 units/day
  • Reduce by 20% when converting from NPH to prevent hypoglycemia: 48 × 0.80 = 38 units of basal insulin (glargine, detemir, or degludec) 22

Step 2: Calculate Prandial NovoLog Needs

  • Estimated prandial component (30% of premix): ~20 units/day
  • Distribute across three meals based on current dosing pattern:
    • Morning: 20 units × (20/68) = 6 units NovoLog
    • Noon: 20 units × (26/68) = 8 units NovoLog
    • Evening: 20 units × (22/68) = 6 units NovoLog

Step 3: Initial Regimen

  • Basal insulin: 38 units once daily (bedtime or morning depending on agent)
  • NovoLog: 6 units before breakfast, 8 units before lunch, 6 units before dinner
  • Total daily NovoLog: 20 units
  • Total daily insulin: 58 units (38 basal + 20 prandial)

Critical Caveats

The 20% reduction in total daily dose is essential because:

  1. NPH has significant overlap and unpredictable peaks that may have been causing unrecognized hypoglycemia
  2. Modern basal analogs provide more consistent coverage
  3. NovoLog's faster onset (40-50 min vs 80-120 min for regular insulin) provides more predictable prandial control 11

Close monitoring is mandatory:

  • Check fasting glucose to titrate basal insulin (increase 2 units every 3 days until fasting goal reached) 22
  • Check pre-meal and 2-hour post-meal glucose to adjust individual NovoLog doses
  • If hypoglycemia occurs, reduce corresponding dose by 10-20% 22

Common Pitfalls to Avoid

  1. Never convert unit-for-unit to NovoLog alone—this eliminates all basal coverage and will cause severe hyperglycemia
  2. Don't use the full 68 units initially—the 20% reduction prevents hypoglycemia during transition
  3. Don't forget glucagon prescription for emergency hypoglycemia 2
  4. Avoid giving NovoLog 30 minutes before meals like regular insulin—it should be given immediately before eating 11

Research supports that unit-for-unit switching works well when converting between similar premixed formulations (e.g., human premix 30/70 to insulin aspart premix 30/70) 3, but this question asks about converting to a prandial-only insulin, which requires the basal-bolus restructuring outlined above per current guidelines 2222.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.